Follow the money! The esteemed investor site The Motley Fool explained this week: The drug (Remdesivir) could see over $1 billion in sales in the course of the entire coronavirus outbreak, due to the sheer number of patients infected and potentially at risk for the virus. This is assuming the drug can treat up to … Continue reading China Set to Patent Gilead’s Experimental Coronavirus Drug